title: General medicine.
authors.affiliation: Royal Brompton Hospital, London. a.moore@ic.ac.uk
authors.forename: A J
authors.initials: AJ
authors.lastname: Moore
authors.forename: M
authors.initials: M
authors.lastname: Dayer
authors.forename: E
authors.initials: E
authors.lastname: Swallow
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D015179:Colorectal Neoplasms / Q000188:drug therapy / Q000517:prevention & control*; D003327:Coronary Disease / Q000628:therapy*; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use*; D006801:Humans; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors; D029424:Pulmonary Disease, Chronic Obstructive / Q000628:therapy*; D015607:Stents; D020521:Stroke / Q000188:drug therapy*; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D010959:Tissue Plasminogen Activator